Skip to Content

Eliglustat

In the US, Eliglustat (eliglustat systemic) is a member of the drug class miscellaneous metabolic agents and is used to treat Gaucher Disease.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A16AX10

CAS registry number (Chemical Abstracts Service)

0491833-29-5

Chemical Formula

C23-H36-N2-O4

Molecular Weight

404

Therapeutic Categories

Glycosylceramide synthase inhibitor

Treatment of Gaucher disease

Chemical Name

N-{(1R,2R)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl}octanamide (WHO)

Foreign Names

  • Eliglustatum (Latin)
  • Eliglustat (German)
  • Eliglustat (French)
  • Eliglustat (Spanish)

Generic Names

Brand Names

  • Cerdelga
    Genzyme, Germany; Genzyme, France; Genzyme, Macedonia; Genzyme, United States

International Drug Name Search

Glossary

TermDefinition
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide